Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label telaprevir-incivek. Show all posts
Showing posts with label telaprevir-incivek. Show all posts
Wednesday, October 1, 2014

Hepatitis C:Drug–drug interaction (DDI) may not be reflected in prescribing information

›
Medication use and medical comorbidity in patients with chronic hepatitis C  The latest issue of the European Journal of Gastroenterolog...
Tuesday, August 12, 2014

Vertex to stop selling hepatitis C drug Incivek

›
Vertex to stop selling hepatitis C drug Incivek Boston Globe By Robert Weisman  | Globe Staff   Aug...
Monday, August 4, 2014

15 hepatitis C patients die of drug’s side effects

›
15 hepatitis C patients die of drug’s side effects 2:48 am, August 05, 2014  The Yomiuri Shimbun Fifteen hepatitis C patients who were...
Friday, July 4, 2014

Study Begins To Define How Long HCV Patients May Need Treatment

›
Study Begins To Define How Long HCV Patients May Need Treatment As new treatments for hepatitis C virus are approved, Andrew H. Talal, MD...

Incidence and Management of Rash in Telaprevir-Treated Patients: Lessons for Simeprevir?

›
Incidence and Management of Rash in Telaprevir-Treated Patients: Lessons for Simeprevir?  Ann Pharmacother. 2014 Jun 17. pii: 10600280145...
Thursday, May 29, 2014

How Long Should HCV Treatment Last? Study Suggests Answers Are Complex

›
How Long Should HCV Treatment Last? Study Suggests Answers Are Complex Translational researchers tracked in real-time how virus replicates...
1 comment:
Thursday, May 1, 2014

Vertex ends hepatitis C investment as sales fall

›
Vertex ends hepatitis C investment as sales fall NEW YORK (AP) — Vertex Pharmaceuticals, which reported more than $1 billion in sales of i...
Monday, December 9, 2013

Boceprevir vs Telaprevir: Comparison of Hepatitis C virus protease inhibitors in the USA

›
Comparison of Hepatitis C virus protease inhibitors in the USA Full Text Available, here The most recent issue of the Alimentary Pharmaco...
Tuesday, November 26, 2013

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir

›
Alimentary Pharmacology & Therapeutics Early View (Online Version of Record published before inclusion in an issue) Effect of fibros...
Wednesday, November 13, 2013

Costs for Hepatitis C Treatment Skyrocket

›
Medscape Costs for Hepatitis C Treatment Skyrocket Miriam E. Tucker November 13, 2013 WASHINGTON, DC — The expense of telaprevir-base...
Thursday, November 7, 2013

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

›
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C M Colombo 1 , I Fernández ...